Diabetic retinopathy
- PMID: 20580421
- DOI: 10.1016/S0140-6736(09)62124-3
Diabetic retinopathy
Abstract
Diabetic retinopathy is a common and specific microvascular complication of diabetes, and remains the leading cause of preventable blindness in working-aged people. It is identified in a third of people with diabetes and associated with increased risk of life-threatening systemic vascular complications, including stroke, coronary heart disease, and heart failure. Optimum control of blood glucose, blood pressure, and possibly blood lipids remains the foundation for reduction of risk of retinopathy development and progression. Timely laser therapy is effective for preservation of sight in proliferative retinopathy and macular oedema, but its ability to reverse visual loss is poor. Vitrectomy surgery might occasionally be needed for advanced retinopathy. New therapies, such as intraocular injection of steroids and antivascular endothelial growth-factor agents, are less destructive to the retina than are older therapies, and could be useful in patients who respond poorly to conventional therapy. The outlook for future treatment modalities, such as inhibition of other angiogenic factors, regenerative therapy, and topical therapy, is promising.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Update on the treatment of diabetic retinopathy.Hong Kong Med J. 2007 Feb;13(1):46-60. Hong Kong Med J. 2007. PMID: 17277392 Review.
-
Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.Prescrire Int. 2010 Feb;19(105):35-8. Prescrire Int. 2010. PMID: 20455344 Review.
-
[Angiopathy and the eye].Vnitr Lek. 2010 Apr;56(4):333-9. Vnitr Lek. 2010. PMID: 20465107 Review. Czech.
-
Management of proliferative diabetic retinopathy.Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.
-
Management of diabetic retinopathy.Indian J Ophthalmol. 2000 Dec;48(4):321-30. Indian J Ophthalmol. 2000. PMID: 11340894 Review.
Cited by
-
Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients.Int J Ophthalmol. 2022 Oct 18;15(10):1619-1626. doi: 10.18240/ijo.2022.10.09. eCollection 2022. Int J Ophthalmol. 2022. PMID: 36262859 Free PMC article.
-
NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice.Evid Based Complement Alternat Med. 2015;2015:242517. doi: 10.1155/2015/242517. Epub 2015 Mar 3. Evid Based Complement Alternat Med. 2015. PMID: 25821481 Free PMC article.
-
Neuroprotection as a Therapeutic _target for Diabetic Retinopathy.J Diabetes Res. 2016;2016:9508541. doi: 10.1155/2016/9508541. Epub 2016 Mar 31. J Diabetes Res. 2016. PMID: 27123463 Free PMC article. Review.
-
Effect of Shuangdan Mingmu Capsule on Diabetic Retinopathy in Rats via Regulation of miRNAs.Diabetes Metab Syndr Obes. 2022 Oct 19;15:3181-3194. doi: 10.2147/DMSO.S379611. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 36268199 Free PMC article.
-
Neuroprotection in diabetic retinopathy.Curr Diab Rep. 2012 Aug;12(4):329-37. doi: 10.1007/s11892-012-0284-5. Curr Diab Rep. 2012. PMID: 22581259 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical